Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study

Completed

Conditions: Primary Peritoneal Cancer
Fallopian Tube Cancer
Ovarian Cancer

Interventions: Behavioral: semi-structured interviews

First Posted Date: 2016-10-10

Last Posted Date: 2019-08-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT02928549

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients

Not Applicable

Completed

Conditions: Neuroblastoma

Interventions: Drug: ropivacaine
Device: propofol
Behavioral: Wong-Baker FACES® Pain Rating Scale
Behavioral: Post-procedural quality of life (QOL)

First Posted Date: 2016-10-05

Last Posted Date: 2022-11-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 56

Registration Number: NCT02924324

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Trial of YUMI Uterine Manipulator

Not Applicable

Completed

Conditions: Scheduled for a Total Laparoscopic or Robotic-assisted Hysterectomy
Gynecologic Condition

Interventions: Procedure: YUMI manipulator

First Posted Date: 2016-10-04

Last Posted Date: 2022-05-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT02923544

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent and Follow-Up only), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent and Follow-Up only), Harrison, New York, United States

and more 4 locations

Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer

Phase 2

Active, not recruiting

Conditions: Head and Neck Cancer

Interventions: Radiation: Proton beam radiotherapy (PBRT)
Radiation: Photon intensity modulated radiation therapy (IMRT)

First Posted Date: 2016-10-04

Last Posted Date: 2025-03-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 108

Registration Number: NCT02923570

Locations: 🇺🇸
Baptist Alliance MCI, Miami, Florida, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 6 locations

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Not Applicable

Active, not recruiting

Conditions: Pancreatic Cancer
Advanced Pancreatic Ductal Adenocarcinoma

Interventions: Drug: Gemcitabine
Drug: Nab-paclitaxel
Drug: PEGPH20

First Posted Date: 2016-09-30

Last Posted Date: 2024-07-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 110

Registration Number: NCT02921022

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 7 locations

Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes

Active, not recruiting

Conditions: Ovarian Cancer
Prostate Cancer
Pancreas Cancer

Interventions: Behavioral: Assessments

First Posted Date: 2016-09-28

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1047

Registration Number: NCT02917798

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 2 locations

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Early Phase 1

Active, not recruiting

Conditions: Lung Cancer Screening
Current or Past Cigarette Smoker

Interventions: Behavioral: Surveys
Behavioral: Focus groups
Behavioral: In-depth interviews
Behavioral: Navigation

First Posted Date: 2016-09-26

Last Posted Date: 2025-06-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 99

Registration Number: NCT02914899

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer

Completed

Conditions: Endometrial Cancer
Lymphedema

Interventions: Behavioral: questionnaire

First Posted Date: 2016-09-23

Last Posted Date: 2020-06-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 625

Registration Number: NCT02912767

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

Phase 2

Completed

Conditions: Pediatric Patients With Solid Tumors

Interventions: Procedure: Sentinel Lymph Node Biopsy
Drug: indocyanine green (ICG)

First Posted Date: 2016-09-22

Last Posted Date: 2022-10-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 6

Registration Number: NCT02910726

Locations: 🇺🇸
St. Jude's Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.

Phase 1

Active, not recruiting

Conditions: Multiple Myeloma
Amyloidosis

Interventions: Device: Melphalan
Drug: Pegfilgrastim
Procedure: Autologous Hematopoietic Progenitor Cell Transplant

First Posted Date: 2016-09-21

Last Posted Date: 2024-10-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 46

Registration Number: NCT02909036

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy